- Home
- EXLS vs STVN Comparison
EXLS vs STVN Comparison
Compare EXLS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXLS | STVN |
|---|---|---|
| Founded | 1999 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Business Services | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.2B |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EXLS | STVN |
|---|---|---|
| Price | $30.81 | $15.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $46.80 | $25.13 |
| AVG Volume (30 Days) | ★ 2.4M | 636.8K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.41% |
| EPS Growth | ★ 27.27 | N/A |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $2,087,679,000.00 | N/A |
| Revenue This Year | $12.85 | $10.26 |
| Revenue Next Year | $10.65 | $10.02 |
| P/E Ratio | ★ $21.08 | $27.15 |
| Revenue Growth | ★ 13.56 | N/A |
| 52 Week Low | $26.94 | $13.91 |
| 52 Week High | $48.79 | $28.00 |
Technical Indicators
Market Signals| Indicator | EXLS | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 39.20 | 42.55 |
| Support Level | $28.62 | $14.03 |
| Resistance Level | $43.51 | $16.69 |
| Average True Range (ATR) | 1.17 | 0.89 |
| MACD | 0.57 | 0.11 |
| Stochastic Oscillator | 64.16 | 25.25 |
Price Performance
Historical ComparisonAbout EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.